Perennial Investment Advisors’s Gilead Sciences GILD Stock Holding History

Perennial Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$335K	Sell	2,404 -353	-13%	-$49.4K	0.03%	362
2025 Q4	$338K	Buy	2,757 +214	+8%	+$26K	0.03%	350
2025 Q3	$282K	Sell	2,543 -411	-14%	-$46.7K	0.02%	379
2025 Q2	$328K	Sell	2,954 -8	-0.3%	-$851	0.03%	330
2025 Q1	$332K	Buy	2,962 +10	+0.3%	+$1.03K	0.04%	303
2024 Q4	$273K	Buy	2,952 +72	+3%	+$6.48K	0.03%	319
2024 Q3	$241K	Buy	+2,880	New	+$220K	0.03%	331
2023 Q4	–	Sell	-2,706	Closed	-$203K	–	357
2023 Q3	$203K	Buy	2,706 +2	+0.1%	+$154	0.04%	308
2023 Q2	$208K	Buy	2,704 +1	+0%	+$80	0.04%	312
2023 Q1	$224K	Buy	2,703 +26	+1%	+$2.15K	0.04%	291
2022 Q4	$230K	Buy	+2,677	New	+$212K	0.09%	183

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Perennial Investment Advisors's GILD Position: Q1 2026 in Review

Perennial Investment Advisors reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $49.4K and leaving 2,404 shares worth $335K. The position accounts for 0.03% of the portfolio, ranked #362.

Perennial Investment Advisors first reported a position in GILD in Q4 2022 and has held it in 11 quarters since. The position peaked at $338K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Perennial Investment Advisors held 2,404 shares of Gilead Sciences worth $335K as of Q1 2026.
Perennial Investment Advisors sold 353 Gilead Sciences shares in Q1 2026, an estimated $49.4K.
Gilead Sciences made up 0.03% of Perennial Investment Advisors's portfolio in Q1 2026, its #362 holding.
Perennial Investment Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 11 quarters since.
Perennial Investment Advisors's Gilead Sciences position peaked at $338K in Q4 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.